Abstract
A new series of 4-alkyl(aryl)-4-tetramethylenesulfoximide-1,1,1-trifluoroalk-3-en-2-ones has been prepared from the O,N-exchange reactions of 4-alkyl(aryl)-4-alkoxy-1,1,1-trifluoroalk-3-en-2-ones with the cyclic S,Stetramethylenesulfoximide in absence of solvent, in good yields. Subsequently, the easy preparation of a new series of a fused heterocyclic system of 3-aryl-5-trifluoromethyl-7,8-dihydro-6H-thieno[2,1-f][1,2]thiazine 1-oxide derivatives (60- 85% yields) from intramolecular cyclization reactions of sulfoximide enones employing potassium t-butoxide in diethyl ether at reflux is also reported.
Keywords: Sulfoximides, trifluoromethyl ketones, 1,2-thiazines, enaminoketones
Letters in Organic Chemistry
Title: An Easy Approach to the Synthesis of New Fused 3-Aryl-5- trifluoromethyl-7,8-dihydro-6H-thieno [2,1-f] [1,2] thiazine 1-Oxide System
Volume: 6 Issue: 2
Author(s): Helio G. Bonacorso, Renata P. Vezzosi, Roberta L. Drekener, Nilo Zanatta and Marcos A. P. Martins
Affiliation:
Keywords: Sulfoximides, trifluoromethyl ketones, 1,2-thiazines, enaminoketones
Abstract: A new series of 4-alkyl(aryl)-4-tetramethylenesulfoximide-1,1,1-trifluoroalk-3-en-2-ones has been prepared from the O,N-exchange reactions of 4-alkyl(aryl)-4-alkoxy-1,1,1-trifluoroalk-3-en-2-ones with the cyclic S,Stetramethylenesulfoximide in absence of solvent, in good yields. Subsequently, the easy preparation of a new series of a fused heterocyclic system of 3-aryl-5-trifluoromethyl-7,8-dihydro-6H-thieno[2,1-f][1,2]thiazine 1-oxide derivatives (60- 85% yields) from intramolecular cyclization reactions of sulfoximide enones employing potassium t-butoxide in diethyl ether at reflux is also reported.
Export Options
About this article
Cite this article as:
Bonacorso G. Helio, Vezzosi P. Renata, Drekener L. Roberta, Zanatta Nilo and Martins A. P. Marcos, An Easy Approach to the Synthesis of New Fused 3-Aryl-5- trifluoromethyl-7,8-dihydro-6H-thieno [2,1-f] [1,2] thiazine 1-Oxide System, Letters in Organic Chemistry 2009; 6 (2) . https://dx.doi.org/10.2174/157017809787582726
DOI https://dx.doi.org/10.2174/157017809787582726 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Blood-based Amyloid and Tau Biomarker Tests For Alzheimer’s Disease
Neuroscience and Biomedical Engineering (Discontinued) The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
Current Medicinal Chemistry Gene Technology: An Effective Tool for Development of Water-Stress Tolerant Crops
Current Biotechnology In Silico Prediction Models for Blood-Brain Barrier Permeation
Current Medicinal Chemistry Probable Mechanisms Involved in Immunotoxin Mediated Capillary Leak Syndrome (CLS) and Recently Developed Countering Strategies
Current Molecular Medicine Design, Synthesis and Pharmacological Evaluation of Gastro- Protective Anti-inflammatory Analgesic Agents based on Dual Oxidative Stress / Cyclooxygenase Inhibition
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Advances in Nano Drugs for Cancer Chemotherapy
Current Cancer Drug Targets Therapeutic Antibodies and Other Proteins Obtained by Molecular Display Technologies
Recent Patents on Biotechnology Inflammation Fuels Tumor Progress and Metastasis
Current Pharmaceutical Design Gastrointestinal Safety of Selective COX-2 Inhibitors
Current Pharmaceutical Design Editorial [Hot Topic: Status of Tyrosine Hydroxylase in the Healthy and Parkinson's Brain (Guest Editor: Mohammad Amjad Kamal)]
CNS & Neurological Disorders - Drug Targets Mesenchymal Stem Cells Targeting of Systemic Disorders in Age-related Macular Degeneration
Current Tissue Engineering (Discontinued) Exosome Limitations in the Treatment of Inflammatory Diseases
Current Pharmaceutical Design Small Conductance Ca2+-Activated K+ Channels as Targets of CNS Drug Development
Current Drug Targets - CNS & Neurological Disorders Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Recent Patents on Anti-Cancer Drug Discovery Hypercoagulability in Sickle Cell Disease and Beta-Thalassemia
Current Molecular Medicine Meloxicam Prevents Load-Induced Cardiac Hypertrophy in Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry for Biomarker Discovery in Cutaneous Melanoma
Current Proteomics Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry - Central Nervous System Agents